+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Residual DNA Testing Market - Global Forecast 2026-2032- Product Image
Residual DNA Testing Market - Global Forecast 2026-2032- Product Image
Sale

Residual DNA Testing Market - Global Forecast 2026-2032

  • Report

  • 199 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6160041
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Residual DNA Testing Market is projected to reach USD 322.97 Million in 2026. It is expected to continue growing at a CAGR of 8.96%, reaching USD 542.40 Million by 2032.

Residual DNA Testing: Executive Summary and Strategic Context

Residual DNA testing identifies and measures trace amounts of DNA that remain after biological processing, manufacturing, purification, or treatment. It supports quality control, process validation, contamination assessment, and regulatory documentation across biotechnology, pharmaceuticals, cell and gene therapy, vaccines, and related laboratory workflows. Demand is shaped by stricter expectations for product characterization, reproducibility, patient safety, and defensible analytical evidence.

How Quality Expectations Are Reshaping Residual DNA Testing

The field is shifting from occasional compliance testing toward integrated, risk-based control strategies. Laboratories increasingly emphasize validated sample preparation, fit-for-purpose assay sensitivity, interference management, reference materials, and documented chain of custody. Automation and standardized workflows are also changing operations by improving throughput, reducing manual variability, and supporting comparability across sites. These shifts increase the importance of method lifecycle management rather than one-time assay qualification.

Artificial Intelligence Is Strengthening Analytical Workflows

Artificial intelligence can contribute to residual DNA testing through automated signal interpretation, anomaly detection, image or curve analysis, instrument maintenance, and laboratory scheduling. Its greatest near-term value is likely to come from assisting analysts rather than replacing validated analytical judgment. Effective deployment requires traceable training data, controlled model updates, cybersecurity safeguards, human review, and validation that demonstrates consistent performance under relevant sample conditions. AI-generated outputs should remain subject to documented quality systems and applicable laboratory controls.

Regional Insights Across Global Testing Ecosystems

North America is characterized by mature biopharmaceutical manufacturing, established quality systems, and strong emphasis on validated analytical methods. Europe combines sophisticated regulatory oversight with cross-border manufacturing and the harmonization priorities of the European market. Asia-Pacific is supported by expanding biologics capabilities, substantial manufacturing activity, and rising laboratory standardization, while implementation maturity varies across economies. Latin America is developing testing infrastructure alongside local pharmaceutical and biotechnology production. The Middle East is strengthening healthcare and life-science capabilities, with demand linked to quality modernization and technology transfer. Africa presents a more uneven landscape, where laboratory capacity building, access to specialized instrumentation, and workforce development remain central priorities.

Group-Level Priorities: ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN economies are focused on strengthening regional manufacturing networks, regulatory coordination, and laboratory capabilities, although infrastructure differs among members. BRICS countries represent diverse production and research environments, creating opportunities for method harmonization while requiring attention to local validation practices and supply resilience. The European Union emphasizes common regulatory expectations and cross-border quality comparability. G7 members generally prioritize advanced biomanufacturing, data integrity, and high-assurance testing. GCC countries are investing in healthcare and industrial diversification, making workforce development and technology transfer important. NATO members span varied laboratory systems but share broader interests in resilient supply chains, secure data practices, and continuity of critical health-related manufacturing.

Country Perspectives on Residual DNA Testing Capacity

The United States combines advanced biopharmaceutical development with extensive regulatory and contract-testing capabilities. Canada emphasizes research strength, quality infrastructure, and integration with North American supply chains. Germany, France, Italy, Spain, and the United Kingdom contribute established pharmaceutical and laboratory ecosystems, with continued attention to harmonized methods and data integrity. China and India are expanding biotechnology and manufacturing capacity while strengthening analytical standardization. Japan and South Korea combine sophisticated pharmaceutical, electronics, and laboratory technology capabilities. Australia supports research-driven testing and regulated healthcare production. Brazil and Mexico are developing domestic life-science capacity and quality infrastructure. Russia maintains scientific and industrial capabilities but faces constraints related to international collaboration, equipment access, and supply continuity.

Actions for Leaders Building Reliable Testing Programs

Industry leaders should establish a risk-based testing strategy linked to product type, process stage, and patient or end-user impact. They should qualify sample preparation and amplification methods for relevant matrices, define controls for inhibition and contamination, and maintain reference materials with documented traceability. Investments in automation should be paired with analyst training, instrument qualification, cybersecurity, and audit-ready data governance. Organizations should also diversify critical consumables and service relationships, monitor regional regulatory expectations, and use periodic method reviews to address process changes, new modalities, and emerging analytical risks.

Research Methodology for the Executive Summary

This executive summary uses the specified market category-residual DNA testing-and synthesizes verified, generalizable industry considerations across analytical science, biopharmaceutical quality, laboratory operations, regulatory practice, and regional capability development. The assessment is qualitative and deliberately excludes market estimates, market sizing, market shares, forecasts, and company-specific claims. Regional, group, and country observations are framed as contextual differences in infrastructure, manufacturing maturity, regulation, and adoption conditions rather than as quantitative rankings.

Conclusion: Reliability, Compliance, and Analytical Modernization

Residual DNA testing is becoming an increasingly integrated component of lifecycle quality management. Success depends on analytical validity, robust sample handling, consistent documentation, and the ability to demonstrate control across changing products and production environments. Regional capability differences will continue to influence implementation, while AI and automation can improve efficiency when deployed within disciplined validation and governance frameworks. Leaders that combine scientific rigor with resilient operations will be better positioned to support safe, reproducible, and inspection-ready manufacturing.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Residual DNA Testing Market, by Product
7.1. Introduction
7.2. Instruments
7.2.1. Electrophoresis Systems
7.2.2. PCR Instruments
7.2.3. Sequencers
7.3. Kits And Reagents
7.3.1. Extraction Kits
7.3.2. NGS Reagents
7.3.3. PCR Kits
7.4. Services
7.4.1. Custom Solutions
7.4.2. Outsourcing
8. Residual DNA Testing Market, by Technology
8.1. Introduction
8.2. Capillary Electrophoresis
8.3. Microarray Analysis
8.3.1. CGH Array
8.3.2. SNP Array
8.4. Next Generation Sequencing
8.4.1. Targeted Sequencing
8.4.2. Whole Genome Sequencing
8.5. Polymerase Chain Reaction
8.5.1. Digital
8.5.2. Quantitative
9. Residual DNA Testing Market, by Sample Type
9.1. Introduction
9.2. Blood
9.2.1. Dried Blood Spots
9.2.2. Whole Blood
9.3. Saliva
9.4. Tissue
9.4.1. Fresh Tissue
9.4.2. Frozen Tissue
9.4.3. Paraffin Embedded
10. Residual DNA Testing Market, by Application
10.1. Introduction
10.2. Clinical Diagnostics
10.2.1. Genetic Disorder Screening
10.2.2. Oncology
10.3. Forensic Testing
10.4. Research Applications
10.4.1. Academic Research
10.4.2. Pharma R&D
11. Residual DNA Testing Market, by End User
11.1. Introduction
11.2. Diagnostic Centers
11.3. Hospitals
11.4. Research Institutions
12. Residual DNA Testing Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Residual DNA Testing Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Residual DNA Testing Market, by Country
14.1. Introduction
14.2. United States
14.3. China
14.4. Germany
14.5. United Kingdom
14.6. India
14.7. Japan
14.8. Russia
14.9. Brazil
14.10. Canada
14.11. Italy
14.12. Mexico
14.13. France
14.14. Spain
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. ATCC
16.2. Bio-Rad Laboratories, Inc.
16.3. Charles River Laboratories International, Inc.
16.4. Creative Biogene Co., Ltd.
16.5. Cygnus Technologies Ltd.
16.6. Eagle Biosciences, Inc.
16.7. Eurofins Scientific (Ireland) Limited
16.8. ExCell Bio Group
16.9. F. Hoffmann-La Roche AG
16.10. FUJIFILM Wako Pure Chemical Corporation
16.11. Generi Biotech S.L.
16.12. Intertek Group plc
16.13. Jiangsu Hillgene Biopharma Co., Ltd.
16.14. Merck KGaA
16.15. Minerva Biolabs GmbH
16.16. MtoZ Biolabs Inc.
16.17. QIAGEN N.V.
16.18. RayKol Group Corp., Ltd.
16.19. Shanghai Jinbo Biotechnology Co., Ltd.
16.20. Thermo Fisher Scientific Inc.
16.21. Wuhan Hzymes Biotechnology Co., Ltd.
16.22. Yeasen Biotechnology (Shanghai) Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Residual DNA Testing Market, Years Considered for the Study
FIGURE 2. Global Residual DNA Testing Market, Research Design
FIGURE 3. Global Residual DNA Testing Market, Research Framework
FIGURE 4. Global Residual DNA Testing Market, Data Triangulation
FIGURE 5. Global Residual DNA Testing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Residual DNA Testing Market Size, by Product, 2025 vs 2032 (%)
FIGURE 7. Global Residual DNA Testing Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Residual DNA Testing Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Residual DNA Testing Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Residual DNA Testing Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Residual DNA Testing Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Residual DNA Testing Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Residual DNA Testing Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Residual DNA Testing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Residual DNA Testing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Residual DNA Testing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Residual DNA Testing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Residual DNA Testing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Residual DNA Testing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Residual DNA Testing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Residual DNA Testing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Residual DNA Testing Market Segmentation & Coverage
TABLE 2. Global Residual DNA Testing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Electrophoresis Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Electrophoresis Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Electrophoresis Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global PCR Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global PCR Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global PCR Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Kits And Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Kits And Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Kits And Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Extraction Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Extraction Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Extraction Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global NGS Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global NGS Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global NGS Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global PCR Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global PCR Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global PCR Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Custom Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Custom Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Custom Solutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Outsourcing Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Outsourcing Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Outsourcing Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 38. Global Capillary Electrophoresis Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Capillary Electrophoresis Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Capillary Electrophoresis Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Microarray Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Microarray Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Microarray Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global CGH Array Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global CGH Array Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global CGH Array Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global SNP Array Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global SNP Array Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global SNP Array Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Targeted Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Targeted Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Targeted Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Whole Genome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Whole Genome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Whole Genome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Polymerase Chain Reaction Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Polymerase Chain Reaction Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Polymerase Chain Reaction Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Digital Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Digital Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Digital Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Quantitative Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Quantitative Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Quantitative Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Residual DNA Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 69. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Dried Blood Spots Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Dried Blood Spots Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Dried Blood Spots Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Fresh Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Fresh Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Fresh Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Frozen Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Frozen Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Frozen Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Paraffin Embedded Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Paraffin Embedded Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Paraffin Embedded Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Residual DNA Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. Global Clinical Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Clinical Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Clinical Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Genetic Disorder Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Genetic Disorder Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Genetic Disorder Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Forensic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Forensic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Forensic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Research Applications Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Research Applications Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Research Applications Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Academic Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Academic Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Academic Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Pharma R&D Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Pharma R&D Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Pharma R&D Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Residual DNA Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Residual DNA Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Residual DNA Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Residual DNA Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Residual DNA Testing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Residual DNA Testing Market Size, by Services, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Residual DNA Testing Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Residual DNA Testing Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Residual DNA Testing Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Residual DNA Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Residual DNA Testing Market Size, by Blood, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Residual DNA Testing Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Residual DNA Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Residual DNA Testing Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 140. Asia-Pacific Residual DNA Testing Market Size, by Research Applications, 2017-2032 (USD Million)
TABLE 141. Asia-Pacific Residual DNA Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. North America Residual DNA Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. North America Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 144. North America Residual DNA Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 145. North America Residual DNA Testing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 146. North America Residual DNA Testing Market Size, by Services, 2017-2032 (USD Million)
TABLE 147. North America Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 148. North America Residual DNA Testing Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 149. North America Residual DNA Testing Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 150. North America Residual DNA Testing Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 151. North America Residual DNA Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 152. North America Residual DNA Testing Market Size, by Blood, 2017-2032 (USD Million)
TABLE 153. North America Residual DNA Testing Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 154. North America Residual DNA Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. North America Residual DNA Testing Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 156. North America Residual DNA Testing Market Size, by Research Applications, 2017-2032 (USD Million)
TABLE 157. North America Residual DNA Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. Latin America Residual DNA Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Latin America Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 160. Latin America Residual DNA Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 161. Latin America Residual DNA Testing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 162. Latin America Residual DNA Testing Market Size, by Services, 2017-2032 (USD Million)
TABLE 163. Latin America Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 164. Latin America Residual DNA Testing Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 165. Latin America Residual DNA Testing Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 166. Latin America Residual DNA Testing Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 167. Latin America Residual DNA Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 168. Latin America Residual DNA Testing Market Size, by Blood, 2017-2032 (USD Million)
TABLE 169. Latin America Residual DNA Testing Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 170. Latin America Residual DNA Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. Latin America Residual DNA Testing Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 172. Latin America Residual DNA Testing Market Size, by Research Applications, 2017-2032 (USD Million)
TABLE 173. Latin America Residual DNA Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Europe Residual DNA Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 175. Europe Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 176. Europe Residual DNA Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 177. Europe Residual DNA Testing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 178. Europe Residual DNA Testing Market Size, by Services, 2017-2032 (USD Million)
TABLE 179. Europe Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 180. Europe Residual DNA Testing Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 181. Europe Residual DNA Testing Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 182. Europe Residual DNA Testing Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 183. Europe Residual DNA Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 184. Europe Residual DNA Testing Market Size, by Blood, 2017-2032 (USD Million)
TABLE 185. Europe Residual DNA Testing Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 186. Europe Residual DNA Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. Europe Residual DNA Testing Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 188. Europe Residual DNA Testing Market Size, by Research Applications, 2017-2032 (USD Million)
TABLE 189. Europe Residual DNA Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Middle East Residual DNA Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Middle East Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 192. Middle East Residual DNA Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 193. Middle East Residual DNA Testing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 194. Middle East Residual DNA Testing Market Size, by Services, 2017-2032 (USD Million)
TABLE 195. Middle East Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 196. Middle East Residual DNA Testing Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 197. Middle East Residual DNA Testing Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 198. Middle East Residual DNA Testing Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 199. Middle East Residual DNA Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 200. Middle East Residual DNA Testing Market Size, by Blood, 2017-2032 (USD Million)
TABLE 201. Middle East Residual DNA Testing Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 202. Middle East Residual DNA Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. Middle East Residual DNA Testing Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 204. Middle East Residual DNA Testing Market Size, by Research Applications, 2017-2032 (USD Million)
TABLE 205. Middle East Residual DNA Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Africa Residual DNA Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 207. Africa Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 208. Africa Residual DNA Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 209. Africa Residual DNA Testing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 210. Africa Residual DNA Testing Market Size, by Services, 2017-2032 (USD Million)
TABLE 211. Africa Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 212. Africa Residual DNA Testing Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 213. Africa Residual DNA Testing Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 214. Africa Residual DNA Testing Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 215. Africa Residual DNA Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 216. Africa Residual DNA Testing Market Size, by Blood, 2017-2032 (USD Million)
TABLE 217. Africa Residual DNA Testing Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 218. Africa Residual DNA Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. Africa Residual DNA Testing Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 220. Africa Residual DNA Testing Market Size, by Research Applications, 2017-2032 (USD Million)
TABLE 221. Africa Residual DNA Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Global Residual DNA Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 223. ASEAN Residual DNA Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 224. ASEAN Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 225. ASEAN Residual DNA Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 226. ASEAN Residual DNA Testing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 227. ASEAN Residual DNA Testing Market Size, by Services, 2017-2032 (USD Million)
TABLE 228. ASEAN Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 229. ASEAN Residual DNA Testing Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 230. ASEAN Residual DNA Testing Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 231. ASEAN Residual DNA Testing Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 232. ASEAN Residual DNA Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 233. ASEAN Residual DNA Testing Market Size, by Blood, 2017-2032 (USD Million)
TABLE 234. ASEAN Residual DNA Testing Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 235. ASEAN Residual DNA Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. ASEAN Residual DNA Testing Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 237. ASEAN Residual DNA Testing Market Size, by Research Applications, 2017-2032 (USD Million)
TABLE 238. ASEAN Residual DNA Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. GCC Residual DNA Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 240. GCC Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 241. GCC Residual DNA Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 242. GCC Residual DNA Testing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 243. GCC Residual DNA Testing Market Size, by Services, 2017-2032 (USD Million)
TABLE 244. GCC Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 245. GCC Residual DNA Testing Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 246. GCC Residual DNA Testing Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 247. GCC Residual DNA Testing Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 248. GCC Residual DNA Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 249. GCC Residual DNA Testing Market Size, by Blood, 2017-2032 (USD Million)
TABLE 250. GCC Residual DNA Testing Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 251. GCC Residual DNA Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. GCC Residual DNA Testing Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 253. GCC Residual DNA Testing Market Size, by Research Applications, 2017-2032 (USD Million)
TABLE 254. GCC Residual DNA Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. European Union Residual DNA Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 256. European Union Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 257. European Union Residual DNA Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 258. European Union Residual DNA Testing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 259. European Union Residual DNA Testing Market Size, by Services, 2017-2032 (USD Million)
TABLE 260. European Union Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 261. European Union Residual DNA Testing Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 262. European Union Residual DNA Testing Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 263. European Union Residual DNA Testing Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 264. European Union Residual DNA Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 265. European Union Residual DNA Testing Market Size, by Blood, 2017-2032 (USD Million)
TABLE 266. European Union Residual DNA Testing Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 267. European Union Residual DNA Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. European Union Residual DNA Testing Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 269. European Union Residual DNA Testing Market Size, by Research Applications, 2017-2032 (USD Million)
TABLE 270. European Union Residual DNA Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. BRICS Residual DNA Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 272. BRICS Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 273. BRICS Residual DNA Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 274. BRICS Residual DNA Testing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 275. BRICS Residual DNA Testing Market Size, by Services, 2017-2032 (USD Million)
TABLE 276. BRICS Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 277. BRICS Residual DNA Testing Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 278. BRICS Residual DNA Testing Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 279. BRICS Residual DNA Testing Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 280. BRICS Residual DNA Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 281. BRICS Residual DNA Testing Market Size, by Blood, 2017-2032 (USD Million)
TABLE 282. BRICS Residual DNA Testing Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 283. BRICS Residual DNA Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 284. BRICS Residual DNA Testing Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 285. BRICS Residual DNA Testing Market Size, by Research Applications, 2017-2032 (USD Million)
TABLE 286. BRICS Residual DNA Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. G7 Residual DNA Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 288. G7 Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 289. G7 Residual DNA Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 290. G7 Residual DNA Testing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 291. G7 Residual DNA Testing Market Size, by Services, 2017-2032 (USD Million)
TABLE 292. G7 Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 293. G7 Residual DNA Testing Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 294. G7 Residual DNA Testing Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 295. G7 Residual DNA Testing Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 296. G7 Residual DNA Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 297. G7 Residual DNA Testing Market Size, by Blood, 2017-2032 (USD Million)
TABLE 298. G7 Residual DNA Testing Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 299. G7 Residual DNA Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 300. G7 Residual DNA Testing Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 301. G7 Residual DNA Testing Market Size, by Research Applications, 2017-2032 (USD Million)
TABLE 302. G7 Residual DNA Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. NATO Residual DNA Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 304. NATO Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 305. NATO Residual DNA Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 306. NATO Residual DNA Testing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 307. NATO Residual DNA Testing Market Size, by Services, 2017-2032 (USD Million)
TABLE 308. NATO Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 309. NATO Residual DNA Testing Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 310. NATO Residual DNA Testing Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 311. NATO Residual DNA Testing Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 312. NATO Residual DNA Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 313. NATO Residual DNA Testing Market Size, by Blood, 2017-2032 (USD Million)
TABLE 314. NATO Residual DNA Testing Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 315. NATO Residual DNA Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 316. NATO Residual DNA Testing Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 317. NATO Residual DNA Testing Market Size, by Research Applications, 2017-2032 (USD Million)
TABLE 318. NATO Residual DNA Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 319. Global Residual DNA Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 320. United States Residual DNA Testing Market Size, 2017-2032 (USD Million)
TABLE 321. United States Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 322. United States Residual DNA Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 323. United States Residual DNA Testing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 324. United States Residual DNA Testing Market Size, by Services, 2017-2032 (USD Million)
TABLE 325. United States Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 326. United States Residual DNA Testing Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 327. United States Residual DNA Testing Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 328. United States Residual DNA Testing Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 329. United States Residual DNA Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 330. United States Residual DNA Testing Market Size, by Blood, 2017-2032 (USD Million)
TABLE 331. United States Residual DNA Testing Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 332. United States Residual DNA Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 333. United States Residual DNA Testing Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 334. United States Residual DNA Testing Market Size, by Research Applications, 2017-2032 (USD Million)
TABLE 335. United States Residual DNA Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 336. China Residual DNA Testing Market Size, 2017-2032 (USD Million)
TABLE 337. China Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 338. China Residual DNA Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 339. China Residual DNA Testing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 340. China Residual DNA Testing Market Size, by Services, 2017-2032 (USD Million)
TABLE 341. China Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 342. China Residual DNA Testing Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 343. China Residual DNA Testing Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 344. China Residual DNA Testing Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 345. China Residual DNA Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 346. China Residual DNA Testing Market Size, by Blood, 2017-2032 (USD Million)
TABLE 347. China Residual DNA Testing Market Size, by Tissue, 2017-2032 (USD Million)
TABLE 348. China Residual DNA Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 349. China Residual DNA Testing Market Size, by Clinical Diagnostics, 2017-2032 (USD Million)
TABLE 350. China Residual DNA Testing Market Size, by Research Applications, 2017-2032 (USD Million)
TABLE 351. China Residual DNA Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 352. Germany Residual DNA Testing Market Size, 2017-2032 (USD Million)
TABLE 353. Germany Residual DNA Testing Market Size, by Product, 2017-2032 (USD Million)
TABLE 354. Germany Residual DNA Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 355. Germany Residual DNA Testing Market Size, by Kits And Reagents, 2017-2032 (USD Million)
TABLE 356. Germany Residual DNA Testing Market Size, by Services, 2017-2032 (USD Million)
TABLE 357. Germany Residual DNA Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 358. Germany Residual DNA Testing Market Size, by Microarray Analysis, 2017-2032 (USD Million)
TABLE 359. Germany Residual DNA Testing Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 360. Germany Residual DNA Testing Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 361. Germany Residual DNA Testing Market Size, by Sample Type, 2017-2032 (US

Companies Mentioned

  • ATCC
  • Bio‑Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Creative Biogene Co., Ltd.
  • Cygnus Technologies Ltd.
  • Eagle Biosciences, Inc.
  • Eurofins Scientific (Ireland) Limited
  • ExCell Bio Group
  • F. Hoffmann-La Roche AG
  • FUJIFILM Wako Pure Chemical Corporation
  • Generi Biotech S.L.
  • Intertek Group plc
  • Jiangsu Hillgene Biopharma Co., Ltd.
  • Merck KGaA
  • Minerva Biolabs GmbH
  • MtoZ Biolabs Inc.
  • QIAGEN N.V.
  • RayKol Group Corp., Ltd.
  • Shanghai Jinbo Biotechnology Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Wuhan Hzymes Biotechnology Co., Ltd.
  • Yeasen Biotechnology (Shanghai) Co., Ltd.

Related Topics

Related Reports

Residual DNA Testing Market - A Global and Regional Analysis: Focus on Offering, Test Type, Technology, Application, End User, Country, and Region - Analysis and Forecast, 2025-2035 - Product Image

Residual DNA Testing Market - A Global and Regional Analysis: Focus on Offering, Test Type, Technology, Application, End User, Country, and Region - Analysis and Forecast, 2025-2035

  • Report
  • 120 Pages
  • Global
From
Residual DNA Testing Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology, Application, End User, Product Type - Product Image

Residual DNA Testing Market Outlook 2026-2034: Market Share, and Growth Analysis by Technology, Application, End User, Product Type

  • Report
  • 160 Pages
  • Global
From
Cell-Free DNA Testing Market - Global Forecast 2026-2032 - Product Image

Cell-Free DNA Testing Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
DNA Testing Market Report 2026 - Product Image

DNA Testing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Residual DNA Testing Market Size, Share & Trends Analysis Report by Product & Service, Test Type, Technology by Application, End-User, Region, and Growth Forecasts, 2026-2033 - Product Image

Residual DNA Testing Market Size, Share & Trends Analysis Report by Product & Service, Test Type, Technology by Application, End-User, Region, and Growth Forecasts, 2026-2033

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.